26 February 2019
By Dr Wendy Winnall - PCFA Research Team
Men with prostate cancer, who have a rising PSA despite hormone therapy, know their cancer is on the move. New treatments are needed to slow cancer growth at this stage. The successful ARAMIS clinical trial has demonstrated that Darolutamide can slow tumour progression, giving these men more time before their cancer spreads. But the path to this drug becoming available in Australia is unclear.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
